The biomedical and healthcare sector in China are innovating and growing at impressive speed, with enormous partnership and investment coming in. What are the key innovations that are reshaping the industry? What investment opportunities are driving growth to the next level, especially for MNC players?
AmCham Shanghai's Healthcare Committee invites you to a read out of the recent Shanghai government's policy support for biomedical innovation (《关于促进本市生物医药产业高质量发展的若干意见》) and a discussion on innovation and investment trends on June 22 from 2-4 pm at the AmCham Shanghai office.Leaders from venture capital firms and healthcare innovation segments will share their perspectives on the regulatory environment, innovation ecosystem, local partnerships and investment opportunities and challenges.
1:45 pm: Registration & networking
2:00 pm: Opening and introduction
2:05 pm: Presentations
- Zhu Rong, Deputy Chief, Division of Biomedical Industry at the Shanghai Municipal Commission of Economy and Informatization上海市经信委生物产业处 朱镕副处长
- Samuel Ngai, Vice President, Danaher Innovation Center
- Lei He, GM, Healthcare, Microsoft
- Sabrina He, Regional Lead Lawyer at Johnson & Johnson Innovation, Asia Pacific
3:10 pm: Panel discussion
4:00pm: Event ends